Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper

SEIFEM (Sorveglianza Epidemiologica delle InFezioni nelle EMopatie), A. Busca, C. Cattaneo, E. De Carolis, G. Nadali, M. Offidani, M. Picardi, A. Candoni, E. Ceresoli, M. Criscuolo, M. Delia, R. Della Pepa, I. Del Principe, R.R. Fanci, F. Farina, N. Fracchiolla, C. Giordano, M. Malagola, F. Marchesi, M. PiedimonteL. Prezioso, A.M. Quinto, A. Spolzino, M.C. Tisi, F. Trastulli, E.M. Trecarichi, P. Zappasodi, M. Tumbarello, L. Pagano

Research output: Contribution to journalArticlepeer-review


The therapeutic armamentarium for the treatment of patients with lymphoproliferative diseases has grown considerably over the most recent years, including a large use of new immunotherapeutic agents. As a consequence, the epidemiology of infectious complications in this group of patients is poorly documented, and even more importantly, the potential benefit of antimicrobial prophylaxis remains a matter of debate when considering the harmful effect from the emergence of multidrug resistant pathogens. The present position paper is addressed to all hematologists treating patients affected by lymphoproliferative malignancies with the aim to provide clinicians with a useful tool for the prevention of bacterial, fungal and viral infections.

Original languageEnglish
Article number103203
JournalCritical Reviews in Oncology/Hematology
Publication statusPublished - 2021


  • Antimicrobial prophylaxis
  • Antimicrobial stewardship.
  • Bacterial
  • Fungal and viral infections
  • Lymphoproliferative disorders
  • antiinfective agent
  • antineoplastic agent
  • acute lymphoblastic leukemia
  • antibiotic prophylaxis
  • antimicrobial stewardship
  • bacterial infection
  • cancer immunotherapy
  • cancer patient
  • chronic lymphatic leukemia
  • hematologic malignancy
  • hematologist
  • human
  • lymphoma
  • lymphoproliferative disease
  • multiple myeloma
  • mycosis
  • nonhuman
  • Review
  • virus infection
  • Anti-Bacterial Agents
  • Anti-Infective Agents
  • Humans
  • Lymphoproliferative Disorders


Dive into the research topics of 'Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper'. Together they form a unique fingerprint.

Cite this